Geode Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3K | Hold |
43,137
| – | – | ﹤0.01% | 4142 |
|
|
2025
Q1 | $88K | Buy |
43,137
+474
| +1% | +$967 | ﹤0.01% | 4069 |
|
|
2024
Q4 | $140K | Buy |
42,663
+2,596
| +6% | +$8.52K | ﹤0.01% | 4001 |
|
|
2024
Q3 | $110K | Buy |
40,067
+4,394
| +12% | +$12.1K | ﹤0.01% | 4080 |
|
|
2024
Q2 | $145K | Buy |
35,673
+15,452
| +76% | +$62.9K | ﹤0.01% | 4022 |
|
|
2024
Q1 | $135K | Buy |
20,221
+2,748
| +16% | +$18.4K | ﹤0.01% | 4061 |
|
|
2023
Q4 | $82.2K | Hold |
17,473
| – | – | ﹤0.01% | 4241 |
|
|
2023
Q3 | $73.2K | Sell |
17,473
-6,117
| -26% | -$25.6K | ﹤0.01% | 4326 |
|
|
2023
Q2 | $74.3K | Buy |
+23,590
| New | +$74.3K | ﹤0.01% | 4421 |
|
|
2023
Q1 | – | Sell |
-7,486
| Closed | -$48K | – | 4806 |
|
|
2022
Q4 | $48K | Sell |
7,486
-21
| -0.3% | -$135 | ﹤0.01% | 4599 |
|
|
2022
Q3 | $97K | Hold |
7,507
| – | – | ﹤0.01% | 4587 |
|
|
2022
Q2 | $111K | Hold |
7,507
| – | – | ﹤0.01% | 4548 |
|
|
2022
Q1 | $279K | Hold |
7,507
| – | – | ﹤0.01% | 4212 |
|
|
2021
Q4 | $430K | Sell |
7,507
-2,410
| -24% | -$138K | ﹤0.01% | 4128 |
|
|
2021
Q3 | $1.01M | Buy |
9,917
+4,695
| +90% | +$480K | ﹤0.01% | 3666 |
|
|
2021
Q2 | $509K | Sell |
5,222
-2,835
| -35% | -$276K | ﹤0.01% | 3935 |
|
|
2021
Q1 | $821K | Buy |
8,057
+672
| +9% | +$68.5K | ﹤0.01% | 3641 |
|
|
2020
Q4 | $726K | Buy |
7,385
+718
| +11% | +$70.6K | ﹤0.01% | 3468 |
|
|
2020
Q3 | $3.21M | Buy |
6,667
+1,359
| +26% | +$654K | ﹤0.01% | 2634 |
|
|
2020
Q2 | $4.12M | Buy |
5,308
+502
| +10% | +$389K | ﹤0.01% | 2448 |
|
|
2020
Q1 | $3.34M | Buy |
4,806
+439
| +10% | +$305K | ﹤0.01% | 2376 |
|
|
2019
Q4 | $4.01M | Buy |
+4,367
| New | +$4.01M | ﹤0.01% | 2592 |
|